Brucellosis: Causes, Symptoms, Transmission and Laboratory Diagnosis

Infectious Disease Research | Bacteriology

Brucellosis: Causes, Symptoms, Transmission and Laboratory Diagnosis

Understanding Brucella infection, its transmission pathways, clinical manifestations and the importance of accurate serological testing.

Introduction to Brucellosis

Brucellosis is a zoonotic bacterial infection caused by bacteria belonging to the genus Brucella. It affects both humans and animals and is considered an important public health concern in many regions around the world.

Several Brucella species are associated with human infection, including Brucella melitensis, Brucella abortus, Brucella suis and Brucella canis. Among these, B. melitensis is a major cause of human brucellosis and is frequently associated with sheep and goats.

Human infections commonly occur through contact with infected animals, consumption of contaminated unpasteurized dairy products or occupational exposure. Early recognition and appropriate laboratory diagnosis are important for managing infection and reducing further transmission.

How Is Brucella Transmitted?

Brucella bacteria can enter the human body through several exposure routes. Transmission is particularly associated with livestock farming, animal handling, food consumption and laboratory work.

  • Contaminated dairy products: Consumption of unpasteurized milk, fresh cheese and other dairy products from infected animals is a major route of human infection.
  • Direct animal contact: Exposure to infected livestock, animal tissues, blood, placentas and reproductive fluids can transmit the bacteria through broken skin or mucous membranes.
  • Inhalation: Airborne bacterial particles or aerosols can cause infection, particularly in occupational and laboratory environments.
  • Occupational exposure: Farmers, veterinarians, slaughterhouse workers and laboratory personnel may face increased exposure risks.

Person-to-person transmission is very rare, although specific transmission routes such as breastfeeding and sexual transmission have occasionally been reported.

Common Symptoms of Brucellosis

Brucellosis can cause a wide range of symptoms, which may appear gradually or suddenly. The incubation period is variable and can range from approximately one week to several months.

Common clinical manifestations include:

  • Intermittent or recurring fever.
  • Excessive sweating, particularly at night.
  • Headache.
  • Muscle and joint pain.
  • Fatigue and general weakness.
  • Loss of appetite and weight loss.
  • Back pain and joint discomfort.

In some cases, brucellosis can become chronic or affect different organs and systems. Complications may include arthritis, spondylitis, inflammation of the heart (endocarditis) and neurological involvement. Appropriate medical assessment is important when infection is suspected.

Laboratory Diagnosis of Brucellosis

Because brucellosis symptoms can resemble those of other bacterial and infectious diseases, laboratory testing plays an essential role in identifying Brucella infection. Different diagnostic approaches may be used depending on the patient's clinical presentation and stage of infection.

1. Serological Testing (IgM and IgG Antibodies)

Serological assays detect antibodies produced by the immune system in response to Brucella antigens. These tests can support the investigation of suspected brucellosis.

  • IgM antibodies: May indicate an early immune response following exposure to Brucella bacteria.
  • IgG antibodies: May indicate an established immune response, previous exposure or ongoing infection.

Antibody responses can vary between individuals. Results should be interpreted alongside clinical symptoms, exposure history and other laboratory findings.

2. Bacterial Culture

Isolation of Brucella bacteria from clinical specimens, including blood or bone marrow, can provide microbiological evidence of infection. However, culture requires specialized laboratory procedures, and Brucella bacteria pose an occupational infection risk through aerosol exposure.

Laboratories must follow appropriate biosafety procedures and established protocols when handling suspected specimens.

3. Molecular Testing (PCR)

Polymerase chain reaction (PCR) methods can detect Brucella genetic material in clinical specimens. Molecular testing may support the identification of infection and can complement conventional serological and microbiological investigations.

The choice of specimen, assay and interpretation criteria depends on the diagnostic method and clinical context.

4. Confirmatory Serological Investigations

Additional serological methods, including the standard agglutination test and other validated assays, may be used to support diagnosis. Comparing antibody levels in paired serum samples can also provide useful information when clinically appropriate.

Why Is Accurate Brucella Testing Important?

Accurate laboratory diagnosis is essential because brucellosis may present with nonspecific symptoms and can be difficult to distinguish from other infectious diseases based on clinical findings alone.

Another diagnostic challenge is serological cross-reactivity. Antibodies against Brucella may react with certain other bacterial antigens, potentially affecting the interpretation of antibody-based tests.

Additionally, antibody levels can remain detectable after previous infection or treatment. Therefore, a positive IgG or IgM result should not automatically be considered proof of active infection.

Important Diagnostic Consideration

Serological screening should be interpreted alongside clinical findings, epidemiological history and appropriate confirmatory investigations. Suspected Brucella specimens must also be handled using suitable laboratory biosafety precautions because of the risk of aerosol transmission.

Brucellosis Prevention and Control

Preventing brucellosis requires appropriate food safety practices, animal health monitoring and occupational protection.

  • Consume pasteurized milk and dairy products.
  • Avoid raw milk and unpasteurized dairy products from unverified sources.
  • Use appropriate protective clothing and gloves when handling livestock and animal tissues.
  • Follow veterinary vaccination and disease-control programs for livestock where applicable.
  • Apply suitable biosafety procedures when handling potentially infected laboratory specimens.
  • Promote awareness among farmers, veterinarians and food industry workers.
Featured Diagnostic Product

Brucella IgG/IgM Rapid Test

Brucella IgG/IgM Rapid Test - Gentaur

The Gentaur Brucella IgG/IgM Rapid Test is a cassette-based immunological screening device designed for the qualitative detection of IgG and IgM antibodies against Brucella in human whole blood, serum or plasma samples.

It can support preliminary serological investigations in professional diagnostic settings. The detection of Brucella-specific antibodies may contribute to the assessment of suspected exposure, but results should be interpreted alongside clinical findings and appropriate confirmatory laboratory methods.

Catalog Number: 1317-GS111101C

Pack Size: 25 Tests/box

Sample Type: Whole Blood / Serum / Plasma

Format: Cassette 4 mm

Storage: 0–40 °C

MOQ: 1000

Supplier: Riomavix Sociedad Limitada, Spain

VIEW PRODUCT

Related Rapid Diagnostic Tests

Explore other antibody-based rapid diagnostic tests available from Gentaur for infectious disease research and laboratory screening:

Catalog Number Product
GS110430C JEV IgG/IgM Rapid Test
GS110126C TB IgG/IgM Rapid Test
GS110137C Measles IgG/IgM Rapid Test
GS110517C Typhoid IgG/IgM Rapid Test
GS110418C Chikungunya IgG/IgM Rapid Test
GS110429C Hantavirus IgG/IgM Rapid Test
GS110236C HAV IgM/IgG Rapid Test
GS110407C Dengue IgM/IgG Rapid Test
GS110306C HSV-II IgM/IgG Rapid Test
GS110421C Zika Virus IgG/IgM Rapid Test

Conclusion

Brucellosis remains an important zoonotic disease with significant implications for human health, veterinary medicine and food safety. Understanding its transmission routes, clinical manifestations and laboratory diagnostic methods is essential for effective disease surveillance and control.

Serological testing, bacterial culture and molecular methods can contribute to the investigation of suspected Brucella infection. IgG/IgM antibody tests can support preliminary screening, while clinical assessment and appropriate confirmatory investigations remain essential for reliable interpretation.

Scientific References

  1. World Health Organization (WHO). Brucellosis – Fact Sheet.
  2. Centers for Disease Control and Prevention (CDC). Brucellosis: Clinical Overview.
  3. Centers for Disease Control and Prevention (CDC). Brucellosis: Diagnosis and Testing.

Explore Diagnostic Products at Gentaur

Discover rapid diagnostic tests, antibodies, laboratory reagents and research products.

EXPLORE GENTAUR
16th Nov 2026

Recent Posts